Showing results (121-130 of 829) with videos related to
Sort By:
Pageof 83
Clinical Science (London, England : 1979)|January 24, 2019
PCSK9 inhibition 2018: riding a new wave of coronary preventionNatalie C Ward, Michael M Page, Gerald F WattsCardiovascular Drugs and Therapy|January 27, 2021
Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin IntoleranceAndrey V Susekov, Ludmila A Korol, Gerald F WattsFuture Cardiology|October 15, 2021
Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3Gerald F Watts, Frederick J Raal, Dick C ChanJournal of the Royal Society of Medicine|May 1, 1988
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemiaR Houlston, J Quiney, G F Watts, et al.Current Opinion in Clinical Nutrition and Metabolic Care|August 31, 2023
Lipoprotein(a) and calcific aortic valve disease: current evidence and future directionsNick S R Lan, Zahid Khan, Gerald F WattsBiofactors (Oxford, England)|June 16, 2011
Coenzyme Q(10) , endothelial function, and cardiovascular diseaseGian Paolo Littarru, Luca Tiano, Romualdo Belardinelli, et al.Diabetes, Obesity & Metabolism|April 12, 2003
Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese menD C Chan, G F Watts, P H R BarrettClinical Science (London, England : 1979)|July 1, 2004
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methodsDick C Chan, P Hugh R Barrett, Gerald F WattsDiabetes, Obesity & Metabolism|June 16, 2005
The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjectsA P James, G F Watts, J C L MamoCurrent Diabetes Reports|January 27, 2007
Metabolic syndrome and cardiometabolic risk in PCOSAndrea J Cussons, Bronwyn G A Stuckey, Gerald F WattsPageof 83